Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.345
-0.115-4.67%
Volume:849.70K
Turnover:2.03M
Market Cap:3.04B
PE:-37.81
High:2.450
Open:2.410
Low:2.330
Close:2.460
52wk High:3.310
52wk Low:1.880
Shares:1.30B
Float Shares:786.49M
Volume Ratio:1.45
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.062
EPS(LYR):-0.062
ROE:-9.86%
ROA:-4.11%
PB:3.83
PE(LYR):-37.81

Loading ...

Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus

Simply Wall St.
·
Jul 20

Founder Led Australian Stocks With The Clearest Growth Story Right Now

Simply Wall St.
·
Jul 17

ASX Biggest Losers

MT Newswires Live
·
Jul 17

Founder Led Stocks For Investors Watching Australian Small Caps Closely

Simply Wall St.
·
Jul 16

Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look

Simply Wall St.
·
Jul 15

Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain

MT Newswires Live
·
Jul 14

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS
·
Jul 14

ASX Stocks Estimated To Be Trading Below Fair Value In July 2026

Simply Wall St.
·
Jul 14

3 Australian Founder Led Stocks Backed By Strong Long Term Themes

Simply Wall St.
·
Jul 13

Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings

Stock Track
·
Jul 13

Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings

Reuters
·
Jul 13

Founder Led Stocks With Real Skin In The Game

Simply Wall St.
·
Jul 12

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?

Simply Wall St.
·
Jul 12

Why Retail Investors Are Tracking These 3 Australian Founder Led Stocks

Simply Wall St.
·
Jul 10

Australia's Mesoblast Hits over Two Week High on Upbeat Ryoncil Revenue

Reuters
·
Jul 10

Stock Track | Mesoblast Soars 5% Intraday on Strong Ryoncil Revenue Results

Stock Track
·
Jul 10

Mesoblast Posts Ryoncil Q4 Net Revenue of $36M

Reuters
·
Jul 10

Ryoncil® Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

THOMSON REUTERS
·
Jul 10

Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026

Dow Jones
·
Jul 10

Mesoblast Ltd - Ryoncil Q4 Net Revenue of Us$36m and Us$115m for Full Year

THOMSON REUTERS
·
Jul 10